Measuring health-related quality of life outcomes in bladder cancer patients using the Bladder Cancer Index (BCI).
نویسندگان
چکیده
BACKGROUND Health-related quality of life (HRQOL) has not been adequately measured in bladder cancer. A recently developed reliable and disease-specific quality of life instrument (Bladder Cancer Index, BCI) was used to measure urinary, sexual, and bowel function and bother domains in patients with bladder cancer managed with several different interventions, including cystectomy and endoscopic-based procedures. METHODS Patients with bladder cancer were identified from a prospective bladder cancer outcomes database and contacted as part of an Institutional Review Board-approved study to assess treatment impact on HRQOL. HRQOL was measured using the BCI across stratified treatment groups. Bivariate and multivariable analyses adjusted for age, gender, income, education, relationship status, and follow-up time were performed to compare urinary, bowel, and sexual domains between treatment groups. RESULTS In all, 315 bladder cancer patients treated at the University of Michigan completed the BCI in 2004. Significant differences were seen in mean BCI function and bother scores between cystectomy and native bladder treatment groups. In addition, urinary function scores were significantly lower among cystectomy patients treated with continent neobladder compared with those treated with ileal conduit (all pairwise P<.05). CONCLUSIONS The BCI is responsive to functional and bother differences in patients with bladder cancer treated with different surgical approaches. Significant differences between therapy groups in each of the urinary, bowel, and sexual domains exist. Among patients treated with orthotopic continent urinary diversion, functional impairments related to urinary incontinence and lack of urinary control account for the low observed urinary function scores.
منابع مشابه
Assessing Symptom Burden in Bladder Cancer: An Overview of Bladder Cancer Specific Health-Related Quality of Life Instruments
Background: A key component to monitoring and investigating patient QOL is through patient reported health related quality of life (HRQOL) outcome measures. Many instruments have been used to assess HRQOL in bladder cancer and each instrument varies in its development, validation, the context of its usage in the literature and its applicability to certain disease states. Objective: In this revi...
متن کاملDevelopment and validation of the Bladder Cancer Index: a comprehensive, disease specific measure of health related quality of life in patients with localized bladder cancer.
PURPOSE We developed and validated a reliable, responsive multidimensional instrument to measure disease specific health related quality of life in bladder cancer survivors treated with local cancer therapy. MATERIALS AND METHODS Instrument content was based on qualitative information obtained from a panel of bladder cancer providers and from patient focus groups. Draft items were piloted and...
متن کاملInequality in Bladder Cancer Screening Uptake: A Cross-Sectional Study in Urban Population
Background and Objective: Bladder cancer is one of the most common malignancies of the urinary system. An important source of health disparities is related to early cancer detection strategies. The aim of the present study was to determine the inequality in bladder cancer screening uptake. Materials and Methods: The current research was a cross-sectional study that was conducted among 1760 peo...
متن کاملBladder cancer index: cross-cultural adaptation into Spanish and psychometric evaluation
BACKGROUND The Bladder Cancer Index (BCI) is so far the only instrument applicable across all bladder cancer patients, independent of tumor infiltration or treatment applied. We developed a Spanish version of the BCI, and assessed its acceptability and metric properties. METHODS For the adaptation into Spanish we used the forward and back-translation method, expert panels, and cognitive debri...
متن کاملA review of biomarkers in the diagnosis of bladder cancer
Bladder cancer is among the ten most common cancers and the ten main causes of cancer-related deaths in the world. Currently, bladder tumors are diagnosed and followed up using a combination of cystoscopy and cytology. In addition, bladder cancer often recurs and can progress if not closely monitored after initial treatment. Constant monitoring of the patient with cystoscopy, which is an invasi...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Cancer
دوره 109 9 شماره
صفحات -
تاریخ انتشار 2007